Notice of Intent to Award a Sole Source Commercial Tender

• Country: USA
• Summary: Notice of Intent to Award a Sole Source Commercial Simplified Acquisition Procedures Sap Purchase Order for Metabolismqualified Cryopreserved Human Hepatocytes
• UST Ref No: 141720923
• Deadline: 29 May 2026
• Financier: Self Financed
• Purchaser Ownership: Government
• Tender Value: Refer Document
• Notice Type: Tender
• Document Ref. No.: CDER-2026-132690
• Purchaser's Detail:
  Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.

  Login to see details
• Description:
• The Food and Drug Administration (FDA) intends to award a Sole Source firm-fixed-price commercial Purchase Order (PO) to BioIVT, LLC (BioIVT), 1450 South Rolling Road, Baltimore, MD, 21227, for the Purchase of Metabolism-Qualified Cryopreserved Human Hepatocytes in accordance with the authority under FAR RFO Part 6.103-1 , Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements.
  BioIVT is the only known source capable of providing metabolism-qualified cryopreserved human hepatocytes meeting the required donor characteristics, viability thresholds, and metabolic activity specifications necessary to support continuity of the FDA research study. A Sources Sought notice was previously posted on SAM.gov and no capability statements or responses were received from interested vendors.
  This acquisition is being conducted using simplified acquisition procedures in accordance with FAR RFO Part 12 for the acquisition of commercial products and commercial services.
  The North American Industry Classification System (NAICS) code for the proposed acquisition is 325414; Biological Product (except Diagnostic) Manufacturing, with a small business standard size of 1,250 employees.
  Deliverables
  The contractor shall provide up to 4 distinct female donor lots totaling 24 vials of cryopreserved human hepatocytes. Delivery must occur within 7 days of award.
  Cryopreserved Human Hepatocytes - Donor Lot 1: Single-donor female metabolism-qualified cryoplatable human hepatocytes (Age 20-35 years), minimum viable cells/vials with 85% post-thaw viability — 6 Vials
  Cryopreserved Human Hepatocytes - Donor Lot 2: Single-donor female metabolism-qualified cryoplatable human hepatocytes (Age 54-70 years), minimum 5 million viable cells/vials with 85% post-thaw viability — 6 Vials
  Cryopreserved Human Hepatocytes - Donor Lot 3: Single-donor female metabolism-qualified cryoplatable human hepatocytes (Age 54-70 years), minimum 5 million vi...
• Documents:

 Tender Notice